NanoBio® Corporation: Making an Impact on the Future of Health Care
Dr. Baker worked closely with UM Tech Transfer specialists to patent hundreds of different formulations for his invention. In 2000, the lure of this amazing technology was powerful enough to draw Ann Arbor businessman and financier Mike Nold out of retirement and into the post of CFO at NanoBio Corporation, a start-up company that holds exclusive rights for licensing the nanoemulsion technology from the University of Michigan.
Currently, the company has eight pharmaceuticals in the pipeline. Two rounds of angel funding were oversubscribed, and the first round of venture funding is expected to generate as much as $20 million.
Printed from: http://www.techtransfer.umich.edu/news_events/success_stories/story_26.php